Microstent offers new hope for stubborn glaucoma
Disease control
Completed
This study tested a small device called the Hydrus Microstent in 217 adults with open-angle glaucoma that was not well controlled with other treatments. The goal was to see if the implant could safely lower eye pressure. After 12 months, many patients had a significant drop in ey…
Phase: NA • Sponsor: Ivantis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC